Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry

por Selvarajah, Abi, Tavenier, Annerieke H, Bor, Wilbert L, Houben, Vital, Rasoul, Saman, Kaplan, Eliza, Teeuwen, Koen, Hofma, Sjoerd H, Lipsic, Erik, Amoroso, Giovanni, van Leeuwen, Maarten A H, ten Berg, Jur M, van ‘t Hof, Arnoud W J, Hermanides, Renicus S
Publicado 2021